United Therapeutics (UTHR) P/E ratio

P/E ratio today
21.8×

United Therapeutics (UTHR) trades at 21.8× its earnings per share over the last twelve months. At the end of fiscal 2025 (December 31, 2025) its P/E ratio was 17.5×. That is 22.1% higher than the 14.3× of fiscal 2024. Figures as of 19 Nov 2026, 08:10 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

P/E ratio today
21.8×
P/E ratio, fiscal 2025
17.5×
Change on fiscal 2024
+22.1%
Highest on record
150.4×fiscal 2009
Lowest on record
8.1×fiscal 2018
Fiscal years on record
162009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

United Therapeutics P/E ratio, in more detail

Today's figure is 24.6% above the fiscal 2025 year-end.

Across the 16 fiscal year-ends on record (2009–2025), the highest was 150.4× in fiscal 2009 and the lowest 8.1× in fiscal 2018. Today's P/E ratio is higher than at 81% of the 16 fiscal year-ends on record; their median is 15.1×.

History · 16 fiscal years

P/E ratio at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

United Therapeutics P/E ratio, year by year

United Therapeutics (UTHR) P/E ratio by fiscal year
Fiscal yearP/E ratioChangeYear endedShare price at year-endDiluted EPS
Today21.8×—$577.34—
202517.5× 22.1% up$487.25$27.86
202414.3× 29.0% up$352.84$24.64
202311.1× 40.1% down$219.89$19.81
202218.5× 13.7% down$278.09$15.00
202121.5× 63.3% up$216.08$10.06
202013.2×—$151.79$11.54
2019——$88.08-$2.39
20188.1× 48.8% down$108.90$13.39
201715.9× 69.0% up$147.95$9.31
20169.4× 23.6% down$143.43$15.25
201512.3× 40.3% down$156.61$12.72
201420.6× 40.2% down$129.49$6.28
201334.5× 268.5% up$113.08$3.28
20129.4× 27.3% down$53.42$5.71
201112.9× 63.8% down$47.25$3.67
201035.5× 76.4% down$63.22$1.78
2009150.4×—$52.65$0.35
2008——$31.27-$1.08

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E.

How to read it

It is the number of years of current profit the price pays for — a high figure means investors expect growth, and it is best judged against the company's own history.

P/E ratio at health care companies of similar size

P/E ratio of United Therapeutics and comparable companies
CompanyP/E ratio
STERIS STE30.8×
United Therapeutics UTHR21.8×
Incyte INCY60.1×
Tenet Healthcare THC7.9×

Price over the last twelve months' earnings per share, as the market data feed reports it.

More on UTHR

United Therapeutics, figure by figure

United Therapeutics (UTHR) overview: price, valuation and scorecardAll health care companies by market value

United Therapeutics P/E ratio: questions and answers

What is United Therapeutics's P/E ratio?

United Therapeutics (UTHR) trades at 21.8× its earnings per share over the last twelve months. At the end of fiscal 2025 (December 31, 2025) its P/E ratio was 17.5×. That is 22.1% higher than the 14.3× of fiscal 2024.

Is United Therapeutics's P/E ratio high or low compared with its own history?

Today's P/E ratio is higher than at 81% of the 16 fiscal year-ends on record; their median is 15.1×.

What are the highest and lowest P/E ratio figures on record for United Therapeutics?

Across the 16 fiscal year-ends on record (2009–2025), the highest was 150.4× in fiscal 2009 and the lowest 8.1× in fiscal 2018.

How is United Therapeutics's P/E ratio calculated?

The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E. For United Therapeutics it is on record here for 16 fiscal years, 2009 to 2025.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “United Therapeutics (UTHR) P/E ratio”, data as of 19 November 2026. https://funkfolio.com/stock/UTHR/pe-ratio

Underlying data: the company's filings with the SEC and Yahoo Finance.